PURPLE ADVOCACY, LLC for DAVITA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
End-stage renal disease reimbursement and policies related to the new End Stage Renal Disease Prospective Payment System; and the new health care law (Public Law 112-25). H.R. 8 - American Taxpayer Relief Act of 2012, specifically Medicare related offsets and impact to the ESRD bundled payment system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT COLLINS | — |
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Health Issues HCR
End-stage renal disease reimbursement and policies related to the new End Stage Renal Disease Prospective Payment System; and the new health care law (Public Law 112-25). H.R. 8 - American Taxpayer Relief Act of 2012, specifically Medicare related offsets and impact to the ESRD bundled payment system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT COLLINS | — |
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.